166 related articles for article (PubMed ID: 16221673)
21. Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3.
Barnett AC; Tsvetanov S; Gamage N; Martin JL; Duggleby RG; McManus ME
J Biol Chem; 2004 Apr; 279(18):18799-805. PubMed ID: 14871892
[TBL] [Abstract][Full Text] [Related]
22. Potent inhibition of human sulfotransferase 1A1 by 17α-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity.
Rohn KJ; Cook IT; Leyh TS; Kadlubar SA; Falany CN
Drug Metab Dispos; 2012 Aug; 40(8):1588-95. PubMed ID: 22593037
[TBL] [Abstract][Full Text] [Related]
23. The gate that governs sulfotransferase selectivity.
Cook I; Wang T; Almo SC; Kim J; Falany CN; Leyh TS
Biochemistry; 2013 Jan; 52(2):415-24. PubMed ID: 23256751
[TBL] [Abstract][Full Text] [Related]
24. The structure of the catechin-binding site of human sulfotransferase 1A1.
Cook I; Wang T; Girvin M; Leyh TS
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14312-14317. PubMed ID: 27911811
[TBL] [Abstract][Full Text] [Related]
25. Oral contraceptives as substrates and inhibitors for human cytosolic SULTs.
Yasuda S; Suiko M; Liu MC
J Biochem; 2005 Mar; 137(3):401-6. PubMed ID: 15809343
[TBL] [Abstract][Full Text] [Related]
26. The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors.
Breton R; Housset D; Mazza C; Fontecilla-Camps JC
Structure; 1996 Aug; 4(8):905-15. PubMed ID: 8805577
[TBL] [Abstract][Full Text] [Related]
27. Isozyme Specific Allosteric Regulation of Human Sulfotransferase 1A1.
Wang T; Cook I; Leyh TS
Biochemistry; 2016 Jul; 55(29):4036-46. PubMed ID: 27356022
[TBL] [Abstract][Full Text] [Related]
28. Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+.
Sawicki MW; Erman M; Puranen T; Vihko P; Ghosh D
Proc Natl Acad Sci U S A; 1999 Feb; 96(3):840-5. PubMed ID: 9927655
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of human catecholamine sulfotransferase.
Bidwell LM; McManus ME; Gaedigk A; Kakuta Y; Negishi M; Pedersen L; Martin JL
J Mol Biol; 1999 Oct; 293(3):521-30. PubMed ID: 10543947
[TBL] [Abstract][Full Text] [Related]
30. Isoform-specific therapeutic control of sulfonation in humans.
Cook I; Wang T; Leyh TS
Biochem Pharmacol; 2019 Jan; 159():25-31. PubMed ID: 30423313
[TBL] [Abstract][Full Text] [Related]
31. Structural and Dynamic Characterizations Highlight the Deleterious Role of SULT1A1 R213H Polymorphism in Substrate Binding.
Dash R; Ali MC; Dash N; Azad MAK; Hosen SMZ; Hannan MA; Moon IS
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835852
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure of mSULT1D1, a mouse catecholamine sulfotransferase.
Teramoto T; Sakakibara Y; Inada K; Kurogi K; Liu MC; Suiko M; Kimura M; Kakuta Y
FEBS Lett; 2008 Nov; 582(28):3909-14. PubMed ID: 18977225
[TBL] [Abstract][Full Text] [Related]
33. Sulfation of "estrogenic" alkylphenols and 17beta-estradiol by human platelet phenol sulfotransferases.
Harris RM; Waring RH; Kirk CJ; Hughes PJ
J Biol Chem; 2000 Jan; 275(1):159-66. PubMed ID: 10617600
[TBL] [Abstract][Full Text] [Related]
34. In silico mechanistic profiling to probe small molecule binding to sulfotransferases.
Martiny VY; Carbonell P; Lagorce D; Villoutreix BO; Moroy G; Miteva MA
PLoS One; 2013; 8(9):e73587. PubMed ID: 24039991
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of the human estrogen sulfotransferase-PAPS complex: evidence for catalytic role of Ser137 in the sulfuryl transfer reaction.
Pedersen LC; Petrotchenko E; Shevtsov S; Negishi M
J Biol Chem; 2002 May; 277(20):17928-32. PubMed ID: 11884392
[TBL] [Abstract][Full Text] [Related]
36. Crystal Structures of Mycobacterium tuberculosis CysQ, with Substrate and Products Bound.
Erickson AI; Sarsam RD; Fisher AJ
Biochemistry; 2015 Nov; 54(45):6830-41. PubMed ID: 26512869
[TBL] [Abstract][Full Text] [Related]
37. A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP.
Hsiao YS; Yang YS
Biochemistry; 2002 Oct; 41(43):12959-66. PubMed ID: 12390022
[TBL] [Abstract][Full Text] [Related]
38. Phenol sulfotransferase 1A1 activity in human liver: kinetic properties, interindividual variation and re-evaluation of the suitability of 4-nitrophenol as a probe substrate.
Tabrett CA; Coughtrie MW
Biochem Pharmacol; 2003 Dec; 66(11):2089-97. PubMed ID: 14609733
[TBL] [Abstract][Full Text] [Related]
39. X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity.
Dajani R; Cleasby A; Neu M; Wonacott AJ; Jhoti H; Hood AM; Modi S; Hersey A; Taskinen J; Cooke RM; Manchee GR; Coughtrie MW
J Biol Chem; 1999 Dec; 274(53):37862-8. PubMed ID: 10608851
[TBL] [Abstract][Full Text] [Related]
40. High accuracy in silico sulfotransferase models.
Cook I; Wang T; Falany CN; Leyh TS
J Biol Chem; 2013 Nov; 288(48):34494-501. PubMed ID: 24129576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
